Sox2, a marker for stem‐like tumor cells in skin squamous cell carcinoma and hedgehog subgroup medulloblastoma
- 24 July 2014
- journal article
- editorial
- Published by Springer Nature in The EMBO Journal
- Vol. 33 (18) , 1984-1986
Abstract
Heterogeneity within tumors is becoming increasingly recognized as an important cause of treatment failure in cancer. Two recent studies use fate‐mapping and limiting dilution transplantation assays to identify SRY (sex determining region Y)‐box 2 (Sox2) as cancer stem‐cell marker and driver of cancer stemness.Keywords
This publication has 10 references indexed in Scilit:
- Quiescent Sox2+ Cells Drive Hierarchical Growth and Relapse in Sonic Hedgehog Subgroup MedulloblastomaCancer Cell, 2014
- SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinomaNature, 2014
- Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like CellsCell, 2014
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened InhibitionCancer Cell, 2014
- Tumour heterogeneity and cancer cell plasticityNature, 2013
- Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like PropertiesCell, 2013
- A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor GrowthCell, 2010
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell SubpopulationsCell, 2010
- Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma CellsCell Stem Cell, 2010
- Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant GliomaNeuron, 2007